These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 895245)
1. [Advantages and disadvantages of bismuth salts in digestive therapy]. Maison E Med Chir Dig; 1977; 6(3):167-70. PubMed ID: 895245 [No Abstract] [Full Text] [Related]
2. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology]. Olive G Therapie; 1980; 35(3):305-6. PubMed ID: 6775384 [No Abstract] [Full Text] [Related]
4. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)]. Bouvet P Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157 [No Abstract] [Full Text] [Related]
5. [Value of a bismuth subnitrate + sorbitol combination (presented in tablets) in digestive pathology]. Dissard P Lyon Med; 1970 Sep; 224(28):95-6. PubMed ID: 5455111 [No Abstract] [Full Text] [Related]
6. [Bismuth subnitrate in gastrointestinal therapeutics]. de Gennes L Laval Med; 1965 Oct; 36(8):787-90. PubMed ID: 5834339 [No Abstract] [Full Text] [Related]
7. [Bismuth subnitrate in the treatment of gastrointestinal disorders]. Thibert F Union Med Can; 1965 Dec; 94(12):1660-2. PubMed ID: 5851654 [No Abstract] [Full Text] [Related]
8. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)]. Eichler I Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997 [TBL] [Abstract][Full Text] [Related]
9. [Contribution to the clinical study of an original combination in digestive pathology]. Bermond P Actual Hepatogastroenterol (Paris); 1966; 2(3):XXXI-XXXVI. PubMed ID: 5994996 [No Abstract] [Full Text] [Related]
10. [Bismuth subnitrate in current intestinal practice]. de Gennes L Presse Med (1893); 1966 Jul; 74(35):1817-8. PubMed ID: 5943744 [No Abstract] [Full Text] [Related]
11. [Clinical trial of bismuth phosphate]. Claude R Bord Med; 1970 May; 3(5):1419. PubMed ID: 5425892 [No Abstract] [Full Text] [Related]
12. [Study of the effects of bismuth phosphate gel in treatment of gastrointestinal disorders]. Paris J; Merveille P Lille Med; 1968 Dec; 13(10):Suppl 7:1038+. PubMed ID: 5720286 [No Abstract] [Full Text] [Related]
13. Pathophysiology of gastrointestinal infections: the role of bismuth subsalicylate. Scottsdale, Arizona, 11-14 February 1988. Proceedings. Rev Infect Dis; 1990; 12 Suppl 1():S1-119. PubMed ID: 2305172 [No Abstract] [Full Text] [Related]
15. The use of bismuth in gastroenterology. The ACG Committee on FDA-Related Matters. American College of Gastroenterology. Marshall BJ Am J Gastroenterol; 1991 Jan; 86(1):16-25. PubMed ID: 1986548 [No Abstract] [Full Text] [Related]
16. [Clinical experimentation with bismuth phosphate]. Monges H; Hancy A Mars Med; 1968; 105(11):909-11. PubMed ID: 5746245 [No Abstract] [Full Text] [Related]
17. [Bismuth subnitrate in digestive therapy]. VIGUIE R Sem Hop; 1958 Oct; 34(46):2298-301. PubMed ID: 13602830 [No Abstract] [Full Text] [Related]
18. [Bismuth subnitrate in the treatment of dyspepsia of diverse etiology]. Pinter EJ Union Med Can; 1965 Dec; 94(12):1663-5. PubMed ID: 5851655 [No Abstract] [Full Text] [Related]
19. Warning against products containing bismuth subsalicylate. Henderson IW Can Med Assoc J; 1980 Nov; 123(9):848. PubMed ID: 7437988 [No Abstract] [Full Text] [Related]
20. [Clinical trial of bismuth phosphate]. Girard M J Med Lyon; 1968 Dec; 49(154):1929-30. PubMed ID: 5751896 [No Abstract] [Full Text] [Related] [Next] [New Search]